Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFrendo, Michela-
dc.contributor.authorTheuma, Ruth-
dc.contributor.authorFava, Stephen-
dc.identifier.citationFrendo, M., Theuma, R., & Fava, S. (2007). Delayed bezafibrate‐induced angio‐oedema in a 68‐year‐old man. British Journal of Clinical Pharmacology, 64(4), 560-561.en_GB
dc.description.abstractBezafibrate is a commonly used drug in the treatment of dyslipdaemia and is generally considered safe.We report a case of angio-oedema occurring after 10 h ingestion of a slow-release formulation of bezafibrate in a 68-year-old man suffering from hypertriglyceridaemia, hypertension and gout, necessitating trachoestomy for relief of respiratory obstruction. To our knowledge, there have been no previous reports of angio-oedema to this drug; two cases of anaphylactic reactions have been reported in the literature [1, 2]. The case is also unusual in that symptoms started several hours after ingestion of the suspected drug and there were multiple, less severe episodes over a period of 22 months.en_GB
dc.publisherWiley Online Libraryen_GB
dc.subjectAngioneurotic edema -- Maltaen_GB
dc.titleDelayed bezafibrate‐induced angio‐oedema in a 68‐year‐old manen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.publication.titleBritish Journal of Clinical Pharmacologyen_GB
Appears in Collections:Scholarly Works - FacM&SMed

Files in This Item:
File Description SizeFormat 
  Restricted Access
52.81 kBAdobe PDFView/Open Request a copy

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.